CPIX vs RUN · rev $10.4M vs P/E 6.0, rev $2.04B
Cumberland Pharmaceuticals Inc (CPIX) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
CPIX currently screens at market cap $86.9M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the CPIX and RUN stock pages for the full models.
Not investment advice.